This is licensed for the treatment of acute herpetic keratitis (dendritic and geographic ulcers) in adults and suitable for prescribing in primary care.
It is recommended nationally that treatment should be with this UK licensed product, including off-label use in children (Specialist Initiation).
To replace Aciclovir 3% eye ointment which has been discontinued in June 2019.
Aciclovir eye ointment 3% (Zovirax®)
RPH - Specialist advice.
Formulary at all other trusts.
June 2019: Discontinuation of Aciclovir 3% eye ointment - GSK the sole supplier of aciclovir eye ointment plans to discontinue it from the worldwide market in 2018. Stock is anticipated to continue to be avaialble in the UK until the end of June 2019. It is recommended nationally that alternative treatment should be with the UK licensed product, ganciclovir, including off-label use in children (specialist initiation).